{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:20:14Z","timestamp":1786990814697,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ijrobp.2019.10.010","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T01:46:39Z","timestamp":1571103999000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial"],"prefix":"10.1016","volume":"106","author":[{"given":"Xin Shelley","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raza H.","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Kai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Garcia-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Cleeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.10.010_bib1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/PPO.0b013e318293238d","article-title":"Chemoradiation for definitive, preoperative, or postoperative therapy of locally advanced non-small cell lung cancer","volume":"19","author":"Feliciano","year":"2013","journal-title":"Cancer J"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpainsymman.2005.04.012","article-title":"Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer","volume":"30","author":"Hickok","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpainsymman.2015.12.316","article-title":"Prospective study of patient-reported symptom burden in patients with non-small-cell lung cancer undergoing proton or photon chemoradiation therapy","volume":"51","author":"Wang","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib4","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1200\/JCO.2006.07.1126","article-title":"Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms","volume":"24","author":"Wang","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpainsymman.2005.05.015","article-title":"Symptom cluster research: Conceptual, design, measurement, and analysis issues","volume":"31","author":"Barsevick","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.bbi.2010.03.009","article-title":"Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy","volume":"24","author":"Wang","year":"2010","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib7","doi-asserted-by":"crossref","first-page":"e109560","DOI":"10.1371\/journal.pone.0109560","article-title":"A pattern of early radiation-induced inflammatory cytokine expression is associated with lung toxicity in patients with non-small cell lung cancer","volume":"9","author":"Siva","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/srao.2000.6590","article-title":"Cancer-related symptoms","volume":"10","author":"Cleeland","year":"2000","journal-title":"Sem Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.10.009","article-title":"Developmental minocycline treatment reverses the effects of neonatal immune activation on anxiety- and depression-like behaviors, hippocampal inflammation, and HPA axis activity in adult mice","volume":"120","author":"Majidi","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainresbull.2018.08.015","article-title":"Chronic minocycline treatment reduces the anxiety-like behaviors induced by repeated restraint stress through modulating neuroinflammation","volume":"143","author":"Liu","year":"2018","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.expneurol.2014.01.017","article-title":"Minocycline protects the\u00a0immature white matter against hyperoxia","volume":"254","author":"Schmitz","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib12","first-page":"26","article-title":"Low level segmentation of motion capture data based on cosine distance","author":"Yang","year":"2015","journal-title":"IEEE"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2008.10.018","article-title":"Minocycline prevents the development of neuropathic pain, but not acute pain: Possible anti-inflammatory and antioxidant mechanisms","volume":"601","author":"Padi","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","article-title":"Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA trial group","volume":"122","author":"Tilley","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib16","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1200\/JCO.2015.62.3918","article-title":"Pan canadian rash trial: A randomized phase III trial evaluating the impact of a prophylactic skin treatment regimen on epidermal growth factor receptor-tyrosine kinase inhibitor-induced skin toxicities in patients with metastatic lung cancer","volume":"34","author":"Melosky","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib17","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.4103\/0976-500X.120966","article-title":"Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review","volume":"4","author":"Leporini","year":"2013","journal-title":"J Pharmacol Pharmacother"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib18","first-page":"6175","article-title":"Prophylactic effect of oral minocycline in combination with topical steroid and skin care against panitumumab-induced acneiform rash in metastatic colorectal cancer patients","volume":"35","author":"Yamada","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib19","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1200\/JCO.2007.12.6987","article-title":"Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption","volume":"25","author":"Scope","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40257-015-0116-x","article-title":"Efficacy of prophylactic minocycline treatment for skin toxicities induced by erlotinib plus gemcitabine in patients with advanced pancreatic cancer: A retrospective study","volume":"16","author":"Shinohara","year":"2015","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib21","doi-asserted-by":"crossref","unstructured":"Gunn GB, Mendoza TR, Garden AS, et\u00a0al. Minocycline for symptom reduction during radiation therapy for head and neck cancer: A randomized clinical trial [e-pub ahead of print]. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-019-04791-4, Accessed April 29,\u00a02019.","DOI":"10.1007\/s00520-019-04791-4"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpainsymman.2019.06.018","article-title":"Minocycline for symptom reduction during oxaliplatin-based chemotherapy for colorectal cancer: A phase II randomized clinical trial","volume":"58","author":"Wang","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib23","first-page":"3407","article-title":"A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408i","volume":"25","author":"Pachman","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib24","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.2147\/OTT.S145613","article-title":"Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer","volume":"10","author":"Ichiki","year":"2017","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib25","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V","article-title":"Assessing symptom distress in cancer patients: The MD Anderson symptom inventory","volume":"89","author":"Cleeland","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1634\/theoncologist.2010-0193","article-title":"Measuring the symptom burden of lung cancer: The validity and utility of the lung cancer module of\u00a0the MD Anderson symptom inventory","volume":"16","author":"Mendoza","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbi.2011.12.007","article-title":"Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy","volume":"26","author":"Wang","year":"2012","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/jnci\/djg014","article-title":"National institutes of health state-of-the-science conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002","volume":"95","author":"Patrick","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaoncol.2016.6914","article-title":"Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: A meta-analysis","volume":"3","author":"Mustian","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib30","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.3747\/co.25.3883","article-title":"Pharmacologic interventions for fatigue in cancer and transplantation: A meta-analysis","volume":"25","author":"Tomlinson","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2014.3248","article-title":"Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing s phase arrest and apoptosis","volume":"32","author":"Liu","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bcp.2015.07.025","article-title":"Minocycline enhances mitomycin c-induced cytotoxicity through down-regulating ERK1\/2-mediated Rad51 expression in human non-small cell lung cancer cells","volume":"97","author":"Ko","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3835(94)90141-4","article-title":"Minocycline as a modulator of chemotherapy and hyperthermia in\u00a0vitro and in\u00a0vivo","volume":"82","author":"Teicher","year":"1994","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib34","doi-asserted-by":"crossref","first-page":"e12452","DOI":"10.1111\/dth.12452","article-title":"Minocycline successfully treats exaggerated granulomatous hypersensitivity reaction to mw immunotherapy","volume":"30","author":"Vinay","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.euroneuro.2016.11.012","article-title":"Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials","volume":"27","author":"Xiang","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0049-0172(98)80035-8","article-title":"Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis","volume":"28","author":"Angulo","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/RHU.0b013e3180690693","article-title":"Minocycline-induced cutaneous polyarteritis nodosa","volume":"13","author":"Tehrani","year":"2007","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S1092852916000638","article-title":"Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia","volume":"22","author":"Solmi","year":"2017","journal-title":"CNS Spectr"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2133.2000.03357.x","article-title":"Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome","volume":"142","author":"Dunphy","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijrobp.2019.10.010_bib40","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2500\/aap.2008.29.3121","article-title":"Minocycline treatment results in reduced oral steroid requirements in adult asthma","volume":"29","author":"Daoud","year":"2008","journal-title":"Allergy Asthma Proc"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619338830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619338830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:44:59Z","timestamp":1759743899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619338830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0360301619338830"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minocycline Reduces Chemoradiation-Related Symptom Burden in Patients with Non-Small Cell Lung Cancer: A Phase 2 Randomized Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}